Skip to content

Effects of Mulligan SNAG in Chronic Nonspecific Low Back Pain

Effects of Mulligan SNAG Compared With Conventional and Sham Therapy in Chronic Nonspecific Low Back Pain

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07415538
Enrollment
30
Registered
2026-02-17
Start date
2026-01-05
Completion date
2026-02-20
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Manuel Therapy, Nonspecific Chronic Low Back Pain, Pain, Physical Therapy

Brief summary

The aim of this randomized controlled study was to compare the effects of Mulligan SNAG added to conventional physiotherapy with conventional physiotherapy alone and sham SNAG on pain, function, proprioception, and functional performance in individuals with chronic nonspecific low back pain.

Interventions

OTHERConventional Physiotherap

Participants in this arm received a standardized conventional physiotherapy program consisting of electrotherapy, thermal modalities, stretching exercises, and core stabilization exercises. The program was administered three times per week for six weeks.

OTHERConventional Physiotherapy + Mulligan SNAG

Participants in this arm received the same conventional physiotherapy program as the control group, combined with Mulligan Sustained Natural Apophyseal Glide (SNAG) techniques applied to the lumbar spine. SNAG techniques were performed by a physiotherapist during active pain-free movements, three times per week for six weeks.

OTHERConventional Physiotherapy + Sham SNAG

Participants in this arm received the standardized conventional physiotherapy program combined with sham SNAG applications. The sham procedure mimicked the positioning and therapist-patient interaction of the SNAG technique but without the application of therapeutic glide force. Interventions were administered three times per week for six weeks.

Sponsors

Biruni University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged between 18 and 65 years * Presence of chronic nonspecific low back pain lasting for at least 6 months * No signs or symptoms of radicular pain or progressive neurological deficit * No history of lumbar spine surgery * No manual therapy, spinal injection, or structured physiotherapy program for low back pain within the last 3 months * Ability to participate in a physiotherapy and exercise program * Willingness to participate in the study and provision of written informed consent

Exclusion criteria

* Specific causes of low back pain (e.g., fracture, tumor, infection, inflammatory spinal disorders) * Presence of radiculopathy or severe neurological impairment * History of spinal surgery * Pregnancy * Severe balance, vestibular, or neurological disorders that may interfere with proprioception testing * Any medical condition contraindicating physical therapy or manual therapy * Participation in another clinical trial or receiving concurrent treatment for low back pain during the intervention period

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensity (VAS)6 weeksPain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst imaginable pain). Participants will be asked to mark their perceived level of low back pain. Higher scores will indicate greater pain intensity.

Secondary

MeasureTime frameDescription
Lumbar Proprioception (Joint Position Sense Error)6 weeksLumbar proprioception will be assessed using a joint position sense (JPS) test. Participants will be asked to reproduce a predefined lumbar position, and the absolute difference between the target angle and the reproduced angle will be recorded as the repositioning error in degrees. Lower values will indicate better proprioceptive accuracy.
Functional Performance (Five Times Sit-to-Stand Test)6 weeksFunctional performance will be evaluated using the Five Times Sit-to-Stand (5xSTS) test. Participants will be instructed to stand up and sit down five times as quickly as possible from a standard chair without using their arms. The total time to complete the task will be recorded in seconds, with shorter times indicating better functional performance.
Functional Disability (ODI)6 weeksFunctional disability will be evaluated using the Oswestry Disability Index (ODI), which consists of 10 items assessing limitations related to low back pain. Each item is scored from 0 to 5, and the total score is expressed as a percentage, with higher scores indicating greater disability.
Kinesiophobia (Tampa Scale of Kinesiophobia)6 weeksKinesiophobia will be measured using the Tampa Scale of Kinesiophobia (TSK-17), a 17-item self-reported questionnaire scored on a 4-point Likert scale. Total scores range from 17 to 68, with higher scores indicating greater fear of movement and re-injury.
Global Rating of Change (GRC)At week 6 of the interventionPerceived overall change will be assessed using the Global Rating of Change (GRC) scale. Participants will be asked to rate their overall change in condition compared with baseline on a Likert-type scale ranging from -7 (very much worse) to +7 (very much better). Higher positive scores will indicate greater perceived improvement.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026